Anesthesia is a medical term which means insensitivity to pain. Anesthesia is widely used during surgical procedures to render patients unconscious. Spinal-epidural anesthesia is a type of anesthesia for almost any patient of any age. It is injected near the spinal cord and nerve roots. It helps in blocking the pain in the entire body. Spinal-epidural anesthesia combines the rapidity of onset and predictability of a spinal block, with the ability to modify and extend the block through an epidural. Combined spinal and epidural anesthesia technique also allows for post-operative pain relief via epidural patient controlled anesthesia. New surgical procedures have increased the life expectancy in individuals. The geriatric population is highly prone to degenerative diseases and chronic illnesses have increased number of surgeries and therapeutics performed annually, worldwide.
Distinct advantages of combined spinal-epidural anesthesia over general anesthesia such as reduced post anesthesia discomfort as compared to general anesthesia such as nausea, dryness of respiratory tract, and avoidance of other general anesthesia complications. Bronchospasm, trauma to lips, pharynx, vocal cords, prolonged paralysis, and malignant hyperthermia, are some of the reasons leading to increasing patient compliance and growing adoption of the combined spinal-epidural anesthesia set among healthcare providers around the world. Increase in prevalence of spinal cord injury is expected to propel the market during the forecast period. According to the National Spinal Cord Injury Statistical Center, an estimated 282,000 people in the U.S. lived with spinal cord injury in 2016 and the annual incidence of spinal cord injury (SCI) is approximately 17,000 new SCI cases each year.
The global combined spinal-epidural anesthesia sets market can be segmented based on product type, application, end-user, and region. In terms of product type, the market can be categorized into kits (trays and sets), needles, catheters, monitoring systems, and accessories. Based on application, the global combined spinal-epidural anesthesia sets market can be classified into hip replacement surgery, hysterectomy, knee surgery, cesarean section, emergency cesarean section, femur fracture, and others. In terms of end-user, the market can be divided into hospitals, clinics, ambulatory surgical centers, and others.
Geographically, the global combined spinal-epidural anesthesia sets market can be segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2016 owing to increase in the number of surgical procedures performed by combined spinal-epidural anesthesia sets along with rise in patient compliance, new product and techniques being introduced in the market by major players, and growing demand for combined spinal-epidural anesthesia products from patients and health care providers. According to the American Academy of Orthopedic Surgeons (AAOS), in 2012, an estimated 1.5 million orthopedic or musculoskeletal surgeries were performed in the U.S., which included total hip replacement, spinal fusion, and total knee replacement. Europe is expected to be the second largest market in terms of revenue and the market is expected to grow during the forecast period due to increase in adoption of technologically advanced products and rise in incidence of sports injuries. According to the European Commission, annually, about 6.1 million people are being treated in hospitals for a sports injury. Of these about 7% (or 420,000 cases) have to be admitted for further treatment. Asia Pacific is expected to register high growth from 2017 to 2025, due to factors such as increase in prevalence of orthopedic and sports injuries, large and aging patient population, and growing awareness and adoption of combined spinal-epidural anesthesia sets in the region.
Key players operating in the global combined spinal-epidural anesthesia sets market include B. Braun Melsungen AG, Becton, Dickinson and Company, PAJUNK GmbH, Smiths Medical, Hull Anesthesia, and Teleflex Incorporated.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.